Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature


Batu E. D. , Sonmez H. E. , HAZIROLAN T., ÖZALTIN F., BİLGİNER Y., ÖZEN S.

SEMINARS IN ARTHRITIS AND RHEUMATISM, vol.46, no.4, pp.529-535, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 46 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.1016/j.semarthrit.2016.07.012
  • Journal Name: SEMINARS IN ARTHRITIS AND RHEUMATISM
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.529-535
  • Keywords: Child, Takayasu arteritis, Tocilizumab, Treatment, RHEUMATOLOGY 1990 CRITERIA, DISEASE-ACTIVITY, TNF-ALPHA, CLASSIFICATION, CHILDREN, EFFICACY, INTERLEUKIN-6, VASCULITIS

Abstract

Objective: Our aim was to describe our experience with tocilizumab (interleukin 6 receptor antagonist) treatment in children with Takayasu arteritis and to review previous studies regarding tocilizumab use in Takayasu arteritis patients.